Cargando…

Different mutations in SARS-CoV-2 associate with severe and mild outcome

INTRODUCTION: Genomic alterations in a viral genome can lead to either better or worse outcome and identifying these mutations is of utmost importance. Here, we correlated protein-level mutations in the SARS-CoV-2 virus to clinical outcome. METHODS: Mutations in viral sequences from the GISAID virus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagy, Ádám, Pongor, Sándor, Győrffy, Balázs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755579/ https://www.ncbi.nlm.nih.gov/pubmed/33347989 http://dx.doi.org/10.1016/j.ijantimicag.2020.106272

Ejemplares similares

COVIDOUTCOME—estimating COVID severity based on mutation signatures in the SARS-CoV-2 genome
por: Nagy, Ádám, et al.
Publicado: (2021)

KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer
por: Nagy, Ádám, et al.
Publicado: (2016)

Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer
por: Menyhárt, Otília, et al.
Publicado: (2019)

Primary Founder Mutations in the PRKDC Gene Increase Tumor Mutation Load in Colorectal Cancer
por: Pálinkás, Hajnalka Laura, et al.
Publicado: (2022)

Uncovering Potential Therapeutic Targets in Colorectal Cancer by Deciphering Mutational Status and Expression of Druggable Oncogenes
por: Menyhart, Otília, et al.
Publicado: (2019)

A Network-Based Target Overlap Score for Characterizing Drug Combinations: High Correlation with Cancer Clinical Trial Results
por: Ligeti, Balázs, et al.
Publicado: (2015)

A snapshot of 3649 Web-based services published between 1994 and 2017 shows a decrease in availability after 2 years
por: Ősz, Ágnes, et al.
Publicado: (2017)

Neuroradiological Features of Mild and Severe SARS-CoV-2 Infection
por: Pan, Simon, et al.
Publicado: (2020)

TP53 mutation hits energy metabolism and increases glycolysis in breast cancer
por: Harami-Papp, Hajnalka, et al.
Publicado: (2016)

Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases
por: Carsetti, Rita, et al.
Publicado: (2020)

SARS-CoV-2 Point Mutation and Deletion Spectra and Their Association with Different Disease Outcomes
por: Martínez-González, Brenda, et al.
Publicado: (2022)

Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection
por: Fodor, Eszter, et al.
Publicado: (2021)

Mutations of SARS-CoV-2 and their impact on disease diagnosis and severity
por: Alquraan, Laiali, et al.
Publicado: (2023)

Durable SARS-CoV-2 B cell immunity after mild or severe disease
por: Ogega, Clinton O., et al.
Publicado: (2020)

Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals
por: Zhang, Fan, et al.
Publicado: (2020)

Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2
por: Tahmasebi, Safa, et al.
Publicado: (2021)

Temporal patterns of nasal symptoms in patients with mild severity SARS-CoV-2 infection
por: Raad, Richard A., et al.
Publicado: (2021)

Correction to: Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection
por: Fodor, Eszter, et al.
Publicado: (2022)

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
por: Pavoni, Vittorio, et al.
Publicado: (2020)

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
por: Yin, Shiyu, et al.
Publicado: (2020)

A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients
por: Pongor, Lőrinc, et al.
Publicado: (2015)

SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19
por: Anderson, Elizabeth M., et al.
Publicado: (2020)

Correction to: Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals
por: Zhang, Fan, et al.
Publicado: (2021)

Brain disorders: Impact of mild SARS-CoV-2 may shrink several parts of the brain
por: Kumar, Puranam Revanth, et al.
Publicado: (2023)

Hotspot Mutations in SARS-CoV-2
por: Saha, Indrajit, et al.
Publicado: (2021)

The Mutational Landscape of SARS-CoV-2
por: Saldivar-Espinoza, Bryan, et al.
Publicado: (2023)

“Mutation blacklist” and “mutation whitelist” of SARS-CoV-2
por: Sun, Yamin, et al.
Publicado: (2022)

Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting
por: Pongor, Lőrinc S., et al.
Publicado: (2020)

Investigating expressed RNA variants that are related to disease severity in SARS-CoV-2-infected patients with mild-to-severe disease
por: Okendo, Javan, et al.
Publicado: (2022)

Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
por: Hu, William T., et al.
Publicado: (2020)

Severity outcomes associated with SARS-CoV-2 XBB variants, an observational analysis
por: Klein, Eili Y., et al.
Publicado: (2023)

Duration of culturable SARS-CoV-2 within different specimens among mild and severe COVID-19 patients: A longitudinal study
por: Baek, Yae Jee, et al.
Publicado: (2021)

Severe and mild-moderate SARS-CoV-2 vaccinated patients show different frequencies of IFNγ-releasing cells: An exploratory study
por: Garofalo, Eugenio, et al.
Publicado: (2023)

Outcome of SARS-CoV-2 infection in patients with severe asthma on biologics
por: Kagohashi, Katsunori, et al.
Publicado: (2022)

The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern
por: Lin, Lixin, et al.
Publicado: (2021)

Screening for Myocardial Injury after Mild SARS-CoV-2 Infection with Advanced Transthoracic Echocardiography Modalities
por: Rácz, Gergely, et al.
Publicado: (2022)

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
por: Wheatley, Adam K., et al.
Publicado: (2021)

Mutations Strengthened SARS-CoV-2 Infectivity
por: Chen, Jiahui, et al.
Publicado: (2020)

Interactive SARS-CoV-2 mutation timemaps
por: Warren, René L., et al.
Publicado: (2021)

SARS-CoV-2 Mutations and their Viral Variants
por: Cosar, Begum, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5p5ln95ca1a0rm252i6djo49gs